HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Li Yu Selected Research

Neoplasm Metastasis (Metastasis)

12/2020Comprehensive analysis of the expression and prognostic value of CXC chemokines in colorectal cancer.
6/2020Long non-coding RNA MALAT1/microRNA 125a axis presents excellent value in discriminating sepsis patients and exhibits positive association with general disease severity, organ injury, inflammation level, and mortality in sepsis patients.
1/2020Entrectinib, a TRK/ROS1 inhibitor with anti-CNS tumor activity: differentiation from other inhibitors in its class due to weak interaction with P-glycoprotein.
10/2019Potential role of circulating long noncoding RNA MALAT1 in predicting disease risk, severity, and patients' survival in sepsis.
1/2019The cell-penetrating FOXM1 N-terminus (M1-138) demonstrates potent inhibitory effects on cancer cells by targeting FOXM1 and FOXM1-interacting factor SMAD3.
5/2018Successful treatment of multisite hemorrhage by several methods in brain metastasis of choriocarcinoma: A case report.
1/2018miRNA-21 and miRNA-223 expression signature as a predictor for lymph node metastasis, distant metastasis and survival in kidney renal clear cell carcinoma.
12/2017The roles and applications of autoantibodies in progression, diagnosis, treatment and prognosis of human malignant tumours.
9/2014Safety and activity of alectinib against systemic disease and brain metastases in patients with crizotinib-resistant ALK-rearranged non-small-cell lung cancer (AF-002JG): results from the dose-finding portion of a phase 1/2 study.
6/2014Osteosarcoma metastasis: prospective role of ezrin.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Li Yu Research Topics

Disease

147Neoplasms (Cancer)
03/2022 - 02/2004
60Infections
02/2022 - 06/2007
55Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
01/2022 - 07/2005
47Leukemia
01/2022 - 03/2001
46Inflammation (Inflammations)
05/2022 - 11/2004
36Cough
02/2022 - 11/2004
19Neoplasm Metastasis (Metastasis)
12/2020 - 11/2002
17COVID-19
12/2022 - 01/2020
17Sepsis (Septicemia)
11/2022 - 03/2015
17Brain Ischemia (Cerebral Ischemia)
06/2022 - 03/2012
17Chronic Cough
01/2021 - 05/2008
16Asthma (Bronchial Asthma)
03/2022 - 11/2004
16Hematologic Neoplasms (Hematological Malignancy)
12/2021 - 01/2002
16Carcinogenesis
12/2021 - 08/2005
15Myelodysplastic Syndromes (Myelodysplastic Syndrome)
11/2021 - 08/2008
15Multiple Myeloma
12/2019 - 12/2006
14Lymphoma (Lymphomas)
01/2021 - 03/2000
13Reperfusion Injury
06/2022 - 12/2015
13Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
01/2022 - 10/2008
13Gastroesophageal Reflux (GERD)
09/2021 - 01/2009
11Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
03/2022 - 05/2014
11Hypoxia (Hypoxemia)
01/2022 - 01/2013
11Starvation
10/2021 - 06/2010
10Endometrial Neoplasms (Endometrial Cancer)
12/2016 - 04/2005
9Breast Neoplasms (Breast Cancer)
12/2022 - 06/2007
9Body Weight (Weight, Body)
07/2022 - 03/2014
9Fibrosis (Cirrhosis)
07/2022 - 03/2014
9Disease Progression
01/2022 - 05/2012
9Neutropenia
01/2022 - 04/2011
8Hypersensitivity (Allergy)
02/2022 - 05/2011
8Nephrotic Syndrome (Syndrome, Nephrotic)
01/2022 - 07/2003
8Hepatocellular Carcinoma (Hepatoma)
12/2021 - 09/2003
8Graft vs Host Disease (Graft-Versus-Host Disease)
01/2020 - 02/2006
8Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
12/2019 - 06/2011
7Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome)
05/2022 - 03/2012
7Lung Neoplasms (Lung Cancer)
01/2022 - 01/2014
7Necrosis
01/2022 - 01/2014
7Uterine Cervical Neoplasms (Cancer of the Cervix)
03/2020 - 02/2011
7Heart Failure
01/2020 - 12/2010
7BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
12/2016 - 06/2007
7Non-Hodgkin Lymphoma (Lymphosarcoma)
08/2014 - 04/2006
6Toxoplasmosis
02/2022 - 06/2012
6Pain (Aches)
01/2022 - 05/2005
6Hemorrhage
01/2022 - 06/2010
6Stroke (Strokes)
11/2021 - 09/2017
6Thrombosis (Thrombus)
09/2021 - 09/2010

Drug/Important Bio-Agent (IBA)

83Proteins (Proteins, Gene)FDA Link
08/2022 - 03/2002
40Biomarkers (Surrogate Marker)IBA
12/2022 - 05/2006
28Messenger RNA (mRNA)IBA
05/2022 - 07/2003
24AntigensIBA
12/2022 - 10/2010
23CytokinesIBA
01/2022 - 03/2000
22Pharmaceutical PreparationsIBA
11/2021 - 02/2004
21DNA (Deoxyribonucleic Acid)IBA
01/2020 - 07/2005
19Biological ProductsIBA
01/2022 - 08/2008
18VaccinesIBA
12/2022 - 12/2008
18DecitabineFDA Link
12/2021 - 05/2009
17MicroRNAs (MicroRNA)IBA
02/2021 - 08/2008
17Long Noncoding RNAIBA
01/2021 - 01/2015
15Interleukin-6 (Interleukin 6)IBA
05/2022 - 03/2000
15Capsaicin (Zostrix)FDA Link
01/2022 - 11/2004
12Therapeutic UsesIBA
01/2022 - 05/2007
11AcidsIBA
01/2022 - 05/2011
11Oxygen (Dioxygen)IBA
01/2022 - 01/2012
10EnzymesIBA
02/2022 - 05/2014
10Indicators and Reagents (Reagents)IBA
02/2022 - 06/2007
10Phosphotransferases (Kinase)IBA
01/2022 - 06/2010
10Anti-Bacterial Agents (Antibiotics)IBA
03/2021 - 12/2010
10Bortezomib (Velcade)FDA Link
12/2012 - 12/2006
9Immunoglobulin G (IgG)IBA
01/2022 - 10/2012
9AntibodiesIBA
01/2021 - 01/2012
8Neutralizing AntibodiesIBA
12/2022 - 11/2014
8Estrogen ReceptorsIBA
01/2022 - 04/2005
8Estrogens (Estrogen)FDA Link
01/2022 - 04/2005
8Transcription Factors (Transcription Factor)IBA
01/2022 - 04/2012
8RNA (Ribonucleic Acid)IBA
01/2021 - 12/2010
8Dexamethasone (Maxidex)FDA LinkGeneric
01/2016 - 03/2000
7CreatinineIBA
01/2022 - 07/2018
7Peptides (Polypeptides)IBA
01/2022 - 09/2009
7Neuroprotective AgentsIBA
02/2021 - 12/2011
7AntioxidantsIBA
01/2021 - 01/2019
7Glucose (Dextrose)FDA LinkGeneric
01/2021 - 10/2017
7C-Reactive ProteinIBA
12/2020 - 02/2016
6Retinaldehyde (Retinal)IBA
08/2022 - 02/2018
6CollagenIBA
07/2022 - 01/2018
6hydroxysafflor yellow AIBA
06/2022 - 07/2017
6salicylhydroxamic acid (SHAM)IBA
05/2022 - 01/2019
6Antiviral Agents (Antivirals)IBA
01/2022 - 02/2009
6Monoclonal AntibodiesIBA
01/2022 - 01/2011
6Anaplastic Lymphoma KinaseIBA
01/2022 - 07/2016
6CateninsIBA
01/2022 - 08/2012
6Circular RNAIBA
12/2021 - 10/2019

Therapy/Procedure

98Therapeutics
07/2022 - 04/2005
32Hematopoietic Stem Cell Transplantation
01/2021 - 11/2007
29Drug Therapy (Chemotherapy)
12/2021 - 06/2007
20Transplantation
01/2021 - 06/2007
16Peripheral Blood Stem Cell Transplantation (Peripheral Stem Cell Transplantation)
02/2021 - 02/2006
15Immunotherapy
01/2022 - 04/2010
12Aftercare (After-Treatment)
10/2020 - 04/2004
9Chinese Traditional Medicine (Traditional Chinese Medicine)
01/2022 - 01/2010
8Stem Cell Transplantation
09/2019 - 01/2002